GAMMA Investing »

Lexeo Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2025-12-31 $497 50 9.94
2024-12-31 $1.6k 245 6.58
2024-06-30 $224 14 16.07

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Tesla Common Stock (TSLA)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Ishares Tr National Mun Etf Etf (MUB)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Visa Inc Com Cl A Common Stock (V)

View all positions for GAMMA Investing

Top funds holding Lexeo Therapeutics

Henderson Group
Frazier Life Sciences Management
Balyasny Asset Management
Vanguard Group
Affinity Asset Advisors
Citadel Advisors
Vestal Point Capital
Woodline Partners
Millennium Management
BlackRock
Point72 Asset Management
ADAR1 Capital Management
Blackstone Group
D1 Capital Partners
683 Capital Management

View all funds holding Lexeo Therapeutics